Literature DB >> 189915

Effect of prolactin on growth and the estrogen receptor level of human breast cancer cells (MCF-7).

S Shafie, S C Brooks.   

Abstract

The intracellular specific 17beta-estradiol binding in the human breast cancer cell line, MCF-7, was shown to be modified by prolactin. Both ovine and human prolactin doubled the estradiol receptor (E2R) level, but the latter was at least 10 times more stimulatory on a concentration basis. Most of the E2R complex (approximately 80%) was transported to the nucleus, and the prolactin stimulation was reflected in an elevated nuclear uptake of the tritiated 17beta-estradiol. Neither ovine nor human prolactin altered the growth rate of the cells when E2R stimulation was maximal. Insulin (10 mug/ml) stimulated tritiated thymidine incorporation and total DNA content but had no apparent effect on E2R concentration. At 10(-4) M, N6,O2'-dibutyrylcyclicadenosine 3':5'-monophosphate increased insulin stimulation of tritiated thymidine incorporation and brought about a prolactin stimulation of apparent DNA synthesis. Theophylline (10(-3) M) blocked both of these effects of N6,O2'-dibutyrylcyclicadenosine 3':5'-monophosphate. The possible mechanism implicating prolactin as an effector of differentiation and growth of MCF-7 cells is discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 189915

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  20 in total

1.  Psychological factors in breast cancer.

Authors:  S Lovestone; T Fahy
Journal:  BMJ       Date:  1991-05-25

2.  Immunohistochemical localization of oestrogen receptors and progesterone receptors in the human ovary throughout the menstrual cycle.

Authors:  T Iwai; Y Nanbu; M Iwai; S Taii; S Fujii; T Mori
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

Review 3.  Progesterone receptors (PR) mediate STAT actions: PR and prolactin receptor signaling crosstalk in breast cancer models.

Authors:  Katherine A Leehy; Thu H Truong; Laura J Mauro; Carol A Lange
Journal:  J Steroid Biochem Mol Biol       Date:  2017-04-23       Impact factor: 4.292

4.  Prolactin and estrogen enhance the activity of activating protein 1 in breast cancer cells: role of extracellularly regulated kinase 1/2-mediated signals to c-fos.

Authors:  Jennifer H Gutzman; Sarah E Nikolai; Debra E Rugowski; Jyoti J Watters; Linda A Schuler
Journal:  Mol Endocrinol       Date:  2005-03-03

5.  Treatment of benign breast disease with bromocriptine.

Authors:  A Mussa; L Dogliotti
Journal:  J Endocrinol Invest       Date:  1979 Jan-Mar       Impact factor: 4.256

6.  Estrogenic effects of phenolphthalein on human breast cancer cells in vitro.

Authors:  P M Ravdin; M van Beurden; V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

7.  Biological differences among MCF-7 human breast cancer cell lines from different laboratories.

Authors:  C K Osborne; K Hobbs; J M Trent
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

Review 8.  Behavioral genetics of the depression/cancer correlation: a look at the Ras oncogene family and the 'cerebral diabetes paradigm'.

Authors:  Janet K Brewer
Journal:  J Mol Neurosci       Date:  2008-06-18       Impact factor: 3.444

9.  Growth of normal mouse vaginal epithelial cells in and on collagen gels.

Authors:  T Iguchi; F D Uchima; P L Ostrander; H A Bern
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

10.  Micromethod for the determination of free and total prolactin receptors: measurement of receptor levels in normal and malignant mammary and prostate tissues.

Authors:  M Ben-David; T Kadar; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.